Alkaline Phosphatase Level in Pregnancy and Its Association With Birth Weight
NCT03187938 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 292
Last updated 2019-08-28
Summary
Alkaline phosphatase is known to be produced by syncytiotrophoblasts in the placenta and its levels are normally increased in pregnancy. Therefore, it would be reasonable to hypothesize that alkaline phosphatase would be low to low normal in cases of low birth weight / intrauterine growth restriction (IUGR)/ placental insufficiency.
Conditions
- Low Birth Weight Infants
Interventions
- DIAGNOSTIC_TEST
-
Testing of Alkaline Phosphatase Levels
Testing of alkaline phosphatase levels at the time of the 24w0d to 28w6d week labs.
Sponsors & Collaborators
-
TriHealth Inc.
lead OTHER
Principal Investigators
-
Donna Lambers, MD · TriHealth Inc.
Eligibility
- Min Age
- 18 Years
- Sex
- FEMALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2017-06-14
- Primary Completion
- 2019-08-05
- Completion
- 2019-08-05
Countries
- United States
Study Locations
More Related Trials
-
Placental Growth and Adverse Pregnancy Outcomes
NCT01669525 ·Status: COMPLETED
-
Snoring in Pregnancy and Adverse Maternal and Fetal Outcomes
NCT01030003 ·Status: COMPLETED
-
Biophysical Profile in Preterm Pregnancies
NCT02561364 ·Status: COMPLETED
-
Renin and Aldosterone Levels in the Preterm Neonate At Risk for Hypertension
NCT01549444 ·Status: COMPLETED
-
Evaluation of Apelin-13 and Apelin-36 in Women With Recurrent Pregnancy Loss
NCT05205044 ·Status: COMPLETED
-
Study to Determine if Serum BNP Levels Are Elevated in Pregnant Women With Pre-Eclampsia
NCT00533871 ·Status: COMPLETED
-
Hypertensive and Normal Pregnancy--Calcium Metabolism and Renin-Angiotensin - SCOR in Hypertension
NCT00005456 ·Status: COMPLETED
-
Search Elevated Serum Alkaline Phosphatase as a Marker of Prenatal Intervillositis Chronic Histiocytic
NCT02668120 ·Status: COMPLETED
-
Consequences of Antiangiogenic Factors Involved in Preeclampsia on Intra-uterine Growth Restricted Preterm Newborn
NCT01648855 ·Status: COMPLETED
-
Urine-plasminogen as a Predictor for Development Of Preeclampsia in Pregnant Women With Type 1 Diabetes Mellitus
NCT01821053 ·Status: COMPLETED
-
Urine and Serum Concentrations of Pregnancy-Associated Compounds During Gestation
NCT03552055 ·Status: COMPLETED
-
In Utero Magnesium Sulfate Exposure: Effects on Extremely-Low-Birth-Weight Infants
NCT01203501 ·Status: COMPLETED
-
Kidney Injury Biomarkers in Preeclampsia
NCT03217916 ·Status: UNKNOWN
-
First Trimester Placental Assessment in the Screening of Preeclampsia and Intrauterine Growth Restriction
NCT02879942 ·Status: COMPLETED
-
Prediction of Late Fetal Growth Restriction Using Cerebroplacental Ratio
NCT04640467 ·Status: UNKNOWN
-
Alternative Blood Pressure Measurements in OB Patients
NCT04291365 ·Status: COMPLETED ·Phase: NA
-
Longitudinal Measures of Leptin in Pregnant Women Who Developed Preeclampsia
NCT01649167 ·Status: COMPLETED
-
Comparison of Blood Pressure Throughout Pregnancy
NCT00452647 ·Status: TERMINATED
-
Plasma Concentration of Biological Markers in Placental Abruption
NCT03782168 ·Status: TERMINATED
-
Urobilinogen, Maternal Weight Loss and Impending Parturition at Term
NCT00826605 ·Status: COMPLETED
-
Association of Biomechanical Changes and Weight Gain Throughout Pregnancy
NCT01315860 ·Status: COMPLETED
-
Renin and Prorenin in Pregnancy
NCT00005207 ·Status: COMPLETED
-
Precision Medicine for Preterm Birth
NCT02173210 ·Status: COMPLETED
-
The Accuracy of Amniotic Fluid Ferning in the Second Trimester in the Diagnosis of Preterm Prelabor Rupture of Membranes
NCT04963465 ·Status: UNKNOWN
-
Determining the Long-Term Effects of Prenatal Dexamethasone Treatment in Children With 21-Hydroxylase Deficiency and Their Mothers
NCT00617292 ·Status: UNKNOWN